317 related articles for article (PubMed ID: 10788577)
1. Metallothionein-null mice are more sensitive than wild-type mice to liver injury induced by repeated exposure to cadmium.
Habeebu SS; Liu J; Liu Y; Klaassen CD
Toxicol Sci; 2000 May; 55(1):223-32. PubMed ID: 10788577
[TBL] [Abstract][Full Text] [Related]
2. Metallothionein-null mice are more susceptible than wild-type mice to chronic CdCl(2)-induced bone injury.
Habeebu SS; Liu J; Liu Y; Klaassen CD
Toxicol Sci; 2000 Jul; 56(1):211-9. PubMed ID: 10869470
[TBL] [Abstract][Full Text] [Related]
3. Metallothionein-I/II null mice are more sensitive than wild-type mice to the hepatotoxic and nephrotoxic effects of chronic oral or injected inorganic arsenicals.
Liu J; Liu Y; Goyer RA; Achanzar W; Waalkes MP
Toxicol Sci; 2000 Jun; 55(2):460-7. PubMed ID: 10828279
[TBL] [Abstract][Full Text] [Related]
4. Metallothionein-I/II null mice are sensitive to chronic oral cadmium-induced nephrotoxicity.
Liu Y; Liu J; Habeebu SM; Waalkes MP; Klaassen CD
Toxicol Sci; 2000 Sep; 57(1):167-76. PubMed ID: 10966523
[TBL] [Abstract][Full Text] [Related]
5. Metallothionein protects against the nephrotoxicity produced by chronic CdMT exposure.
Liu Y; Liu J; Habeebu SS; Klaassen CD
Toxicol Sci; 1999 Aug; 50(2):221-7. PubMed ID: 10478858
[TBL] [Abstract][Full Text] [Related]
6. Cadmium-induced hepatic and renal injury in chronically exposed rats: likely role of hepatic cadmium-metallothionein in nephrotoxicity.
Dudley RE; Gammal LM; Klaassen CD
Toxicol Appl Pharmacol; 1985 Mar; 77(3):414-26. PubMed ID: 3975909
[TBL] [Abstract][Full Text] [Related]
7. Augmented hepatic injury followed by impaired regeneration in metallothionein-I/II knockout mice after treatment with thioacetamide.
Oliver JR; Jiang S; Cherian MG
Toxicol Appl Pharmacol; 2006 Feb; 210(3):190-9. PubMed ID: 15979673
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of MT-null mice to chronic CdCl2-induced nephrotoxicity indicates that renal injury is not mediated by the CdMT complex.
Liu J; Liu Y; Habeebu SS; Klaassen CD
Toxicol Sci; 1998 Nov; 46(1):197-203. PubMed ID: 9928683
[TBL] [Abstract][Full Text] [Related]
9. Metallothionein-null and wild-type mice show similar cadmium absorption and tissue distribution following oral cadmium administration.
Liu Y; Liu J; Klaassen CD
Toxicol Appl Pharmacol; 2001 Sep; 175(3):253-9. PubMed ID: 11559024
[TBL] [Abstract][Full Text] [Related]
10. Metallothionein (MT)-null mice are sensitive to cisplatin-induced hepatotoxicity.
Liu J; Liu Y; Habeebu SS; Klaassen CD
Toxicol Appl Pharmacol; 1998 Mar; 149(1):24-31. PubMed ID: 9512723
[TBL] [Abstract][Full Text] [Related]
11. Chronic combined exposure to cadmium and arsenic exacerbates nephrotoxicity, particularly in metallothionein-I/II null mice.
Liu J; Liu Y; Habeebu SM; Waalkes MP; Klaassen CD
Toxicology; 2000 Jul; 147(3):157-66. PubMed ID: 10924798
[TBL] [Abstract][Full Text] [Related]
12. Metallothionein-null mice are highly susceptible to the hematotoxic and immunotoxic effects of chronic CdCl2 exposure.
Liu J; Liu Y; Habeebu SS; Klaassen CD
Toxicol Appl Pharmacol; 1999 Sep; 159(2):98-108. PubMed ID: 10495773
[TBL] [Abstract][Full Text] [Related]
13. Oleanolic acid protects against cadmium hepatotoxicity by inducing metallothionein.
Liu Y; Kreppel H; Liu J; Choudhuri S; Klaassen CD
J Pharmacol Exp Ther; 1993 Jul; 266(1):400-6. PubMed ID: 8331568
[TBL] [Abstract][Full Text] [Related]
14. Metallothionein plays less of a protective role in cadmium-metallothionein-induced nephrotoxicity than in cadmium chloride-induced hepatotoxicity.
Liu J; Liu Y; Michalska AE; Choo KH; Klaassen CD
J Pharmacol Exp Ther; 1996 Mar; 276(3):1216-23. PubMed ID: 8786554
[TBL] [Abstract][Full Text] [Related]
15. Genetic background but not metallothionein phenotype dictates sensitivity to cadmium-induced testicular injury in mice.
Liu J; Corton C; Dix DJ; Liu Y; Waalkes MP; Klaassen CD
Toxicol Appl Pharmacol; 2001 Oct; 176(1):1-9. PubMed ID: 11578143
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of cadmium-induced testicular injury in metallothionein-III null mice.
Honda A; Komuro H; Shimada A; Hasegawa T; Seko Y; Nagase H; Hozumi I; Inuzuka T; Hara H; Fujiwara Y; Satoh M
Life Sci; 2010 Oct; 87(17-18):545-50. PubMed ID: 20851133
[TBL] [Abstract][Full Text] [Related]
17. Distribution and retention of cadmium in metallothionein I and II null mice.
Liu J; Liu Y; Michalska AE; Choo KH; Klaassen CD
Toxicol Appl Pharmacol; 1996 Feb; 136(2):260-8. PubMed ID: 8619234
[TBL] [Abstract][Full Text] [Related]
18. Effects of perinatal exposure to low doses of cadmium or methylmercury on thyroid hormone metabolism in metallothionein-deficient mouse neonates.
Mori K; Yoshida K; Hoshikawa S; Ito S; Yoshida M; Satoh M; Watanabe C
Toxicology; 2006 Nov; 228(1):77-84. PubMed ID: 16982123
[TBL] [Abstract][Full Text] [Related]
19. Gadolinium chloride pretreatment prevents cadmium chloride-induced liver damage in both wild-type and MT-null mice.
Harstad EB; Klaassen CD
Toxicol Appl Pharmacol; 2002 May; 180(3):178-85. PubMed ID: 12009857
[TBL] [Abstract][Full Text] [Related]
20. Role of metallothionein in cadmium-induced hepatotoxicity and nephrotoxicity.
Klaassen CD; Liu J
Drug Metab Rev; 1997; 29(1-2):79-102. PubMed ID: 9187512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
